Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000862139 | SCV001002598 | likely benign | Spastic paraplegia | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001849155 | SCV002104953 | uncertain significance | Hereditary spastic paraplegia | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003141873 | SCV003820632 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2019-11-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003892784 | SCV004717203 | likely benign | SACS-related disorder | 2022-03-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |